Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial
Clinical trial NCT04847661 · COMPLETED
Trial details
- NCT number
- NCT04847661
- Sponsor
- Helwan University
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-28
- Primary completion
- 2022-06-30
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.